- Top Workplaces
- Novavax
Novavax
Novavax (NVAX), Inc. is a fast-growing, late-stage vaccine company committed to improving health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have created vaccines against some of the world’s most devastating diseases, including seasonal influenza, RSV, Ebola, MERS and SARS. Our recombinant nanoparticle technology platform combines the power and speed of genetic engineering to efficiently produce safe and effective vaccines.
This is an exciting time to be at Novavax. We are working feverishly to advance NVX-CoV2373, our COVID-19 vaccine candidate, and NanoFlu™, our quadrivalent influenza nanoparticle vaccine successfully met all primary objectives in its pivotal Phase 3 trial. Both vaccines incorporate Matrix-M, our proprietary adjuvant, in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Headquartered in Maryland, we also have facilities in Sweden and Prague.
This is an exciting time to be at Novavax. We are working feverishly to advance NVX-CoV2373, our COVID-19 vaccine candidate, and NanoFlu™, our quadrivalent influenza nanoparticle vaccine successfully met all primary objectives in its pivotal Phase 3 trial. Both vaccines incorporate Matrix-M, our proprietary adjuvant, in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Headquartered in Maryland, we also have facilities in Sweden and Prague.